During the past decade, Hudson Valley Heart Center conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 9 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hudson Valley Heart Center" #1 sponsor was "Abbott Medical Devices" with 4 trials, followed by "Medtronic" with 3 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hudson Valley Heart Center" #1 collaborator was "Abbott" with 2 trials as a collaborator, "Duke Clinical Research Institute" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Hudson Valley Heart Center" are "Heart Failure" (6 trials), "Cardiovascular Disease" (3 trials), "Coronary Artery Disease" (3 trials), "Acute Coronary Syndrome" (2 trials) and "Coronary Arteriosclerosis" (2 trials). Many other conditions were trialed in "Hudson Valley Heart Center" in a lesser frequency.

Most popular intervention types in "Hudson Valley Heart Center" are "Drug" (12 trials), "Device" (9 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Apixaban" (2 trials), "Ranolazine" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "Acetylsalicylic acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hudson Valley Heart Center" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Hudson Valley Heart Center". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Hudson Valley Heart Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Hudson Valley Heart Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 5 trials that are defined as “Not Applicable".